# Novel On-body Evaluation of Cardiac Health for Oncology

> **NCT07158450** · — · ENROLLING_BY_INVITATION · sponsor: **Skribe Medical** · enrollment: 50 (estimated)

## Conditions studied

- Cardiotoxicity
- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07158450
- **Lead sponsor:** Skribe Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-10-09
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07158450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07158450, "Novel On-body Evaluation of Cardiac Health for Oncology". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07158450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*